NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:00-14:07 |
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE after Biliary Drainage: TEMP Score |
Wen-Zhe Fan | The First Affiliated Hospital, Sun Yat-Sen University, China |
2 | 14:07-14:14 |
Thermosensitive Nanogel: A Novel Embolic Agent of TACE for HCC |
Rong Ding | Yunnan Provincial Cancer Hospital, China |
3 | 14:14-14:21 |
Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced HCC Patients Receiving TACE plus Systemic Therapies |
Jin-Feng Bai | Yunnan Provincial Cancer Hospital, China |
4 | 14:21-14:28 |
TACE Combined with Systemic Therapy for Unresectable Liver Cancer |
Ning Ai | The Fourth Hospital of Hebei Medical University, China |
5 | 14:28-14:35 |
TACE and TKIs with or without PD-1 as First-line Treatment for Unresectable HCC: A Propensity Score Matching Study |
Xue-Gang Yang | Sichuan Cancer Hospital & Institute, China |
6 | 14:35-14:42 |
MWA vs. RFA Combined with Vertebroplasty for Vertebral Metastatic Tumors: A Retrospective Cohort Study |
Fu-An Wang | Jiangsu Subei People's Hospital, China |
7 | 14:42-15:00 |
Panelists
Hai-Dong Zhu
Zhongda Hospital, Southeast University, China /
Alex Tang
Subang Jaya Medical Centre,Malaysia /
Wen-Zhe Fan
The First Affiliated Hospital, Sun Yat-Sen University, China /
Rong Ding
Yunnan Provincial Cancer Hospital, China /
Jin-Feng Bai
Yunnan Provincial Cancer Hospital, China /
Ning Ai
The Fourth Hospital of Hebei Medical University, China /
Xue-Gang Yang
Sichuan Cancer Hospital & Institute, China /
Fu-An Wang
Jiangsu Subei People's Hospital, China /
Jian-Bo Zhao
Southern Hospital of Southern Medical University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 15:00-15:07 |
Fruquintinib Combined with Sintilimab plus TACE for Unresectable HCC: A Single-arm Phase 2 Study |
Hui Zeng | Zhejiang Provincial Cancer Hospital, China |
2 | 15:07-15:14 |
Predictive Model of Unresectable HCC Treated with TACE-HAIC Combined with TKIs and ICIs |
Li-Nan Yin | Harbin Medical Univisity Cancer Hospital, China |
3 | 15:14-15:21 |
Transformation of IR Workflow through Smart Operating Room Development: Technological Integration and Clinical Practice |
Lin Zhu | Zhongshan Hospital Affiliated with Fudan University, China |
4 | 15:21-15:28 |
Can Commonly Used Large Language Models Be Recommend Interventional Therapy to Liver Cancer Patients? |
Zhi-Hui Chang | Shengjing Hospital of China Medical University, China |
5 | 15:28-15:35 |
Association between TACE Refractoriness and Prognosis in Chinese Patients with HCC: A Retrospective Cohort Study |
Qin-Xue Sun | Ningbo Medical Center Li Huili Hospital, China |
6 | 15:35-16:00 |
Panelists
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Prijo Sidipratomo
Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia /
Hui Zeng
Zhejiang Provincial Cancer Hospital, China /
Li-Nan Yin
Harbin Medical Univisity Cancer Hospital, China /
Lin Zhu
Zhongshan Hospital Affiliated with Fudan University, China /
Zhi-Hui Chang
Shengjing Hospital of China Medical University, China /
Qin-Xue Sun
Ningbo Medical Center Li Huili Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:10 |
Passing the Torch Mentoring Program: Introduction |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
2 | 16:10-16:20 |
Passing the Torch Mentoring Program: Leading Mission I |
Hang Yuan | Henan Cancer Hospital, China |
3 | 16:20-16:30 |
Passing the Torch Mentoring Program: Leading Mission II |
Bing-Jie Zheng | Henan Cancer Hospital, China |
4 | 16:30-16:40 |
Passing the Torch Mentoring Program: Leading Mission IIIa |
Hang Yuan | Henan Cancer Hospital, China |
5 | 16:40-16:50 |
Passing the Torch Mentoring Program: Leading Mission IIIb |
Shi-Jun Xu | Henan Cancer Hospital, China |
6 | 16:50-17:00 |
Passing the Torch Mentoring Program: Leading Mission IV |
Hong-Tao Hu | Henan Cancer Hospital, China |
7 | 17:00-17:10 |
Passing the Torch Mentoring Program: Leading Mission V |
Xi Li | The Fifth Affiliated Hospital of Sun Yat-sen University, China |
8 | 17:10-17:20 |
Passing the Torch Mentoring Program: Leading Mission VI |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
9 | 17:20-18:00 |
Q & A and Panel Discussion (Overcoming Miscommunication & Shaping the Future)
Jiaywei Tsauo
Guangdong Provincial People's Hospital, China /
Bin-Yan Zhong
Zhejiang Cancer Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:00-14:30 |
How to Get Your Paper Published |
Jiaywei Tsauo | Guangdong Provincial People's Hospital, China |
2 | 14:30-14:45 |
The Art of Transforming Ideas into Scientific Investigations |
Bin-Yan Zhong | Zhejiang Cancer Hospital, China |
3 | 14:45-15:00 |
How I Updated My Writing Skills after Publishing My First Paper |
Chu Hui Zeng | Zhongda Hospital Southeast University, China |
4 | 15:00-15:15 |
Top Five Reasons for Writing Scientific Papers |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
5 | 15:15-15:55 |
Panelist
Ho-Young Song
Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China /
Jiaywei Tsauo
Guangdong Provincial People's Hospital, China /
Chu Hui Zeng
Zhongda Hospital Southeast University, China /
Bin-Yan Zhong
Zhejiang Cancer Hospital, China /
Jian Lu
Zhongda Hospital, Southeast University, China /
Xi Li
The Fifth Affiliated Hospital of Sun Yat-sen University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:12 |
Sequential TACE and PVE before Right Pemihepatectomy in Patients with HCC |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
2 | 16:12-16:24 |
Surgical Treatment of HCC with Portal Vein Tumor Thrombus - Progress and Perspectives |
Shu-Qun Cheng | Eastern Hepatobiliary Surgery Hospital, China |
3 | 16:24-16:36 |
TARE for Unresected HCC with Portal Vein Invasion: Which Patient to Treat? |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
4 | 16:36-16:48 |
Precision Radiotherapy and Immune-targeted Therapeutic Strategies in Hepatocellular Carcinoma |
Wei-Hu Wang | Beijing Cancer Hospital, China |
5 | 16:48-17:00 |
ICIs and Anti-VEGF Antibody/TKIs with or without TACE as First-line Treatment for Advanced HCC (CHANCE2201): A Target Trial Emulation Study |
Hai-Tao Zhao | Peking Union Medical College Hospital, China |
6 | 17:00-17:12 |
A Nationwide Target Trial Emulation on the Treatment of Patients with HCC and Main Trunk PVTT Using 125I Irradiation Stents and Combined Therapeutic Approaches (PATENCY II) |
Jian Lu | Zhongda Hospital, Southeast University, China |
7 | 17:12-17:30 |
Panelists
Flavio G. Rocha
Oregon Health and Science University, USA /
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Shu-Qun Cheng
Eastern Hepatobiliary Surgery Hospital, China /
Ajit K. Yadav
Sir Ganga Ram Hospital, Delhi, India /
Wei-Hu Wang
Beijing Cancer Hospital, China /
Hai-Tao Zhao
Peking Union Medical College Hospital, China /
Jian Lu
Zhongda Hospital, Southeast University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:00-13:10 |
Open Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
2 | 13:10-13:30 |
ISMIO Work Report |
Hai-Dong Zhu | Zhongda Hospital, Southeast University, China |
3 | 13:30-13:55 |
General discussion |
||
4 | 13:55-14:15 |
《Multidisciplinary Interventional Oncology》 Book Proposal |
Jian Lu | Zhongda Hospital, Southeast University, China |
5 | 14:15-14:40 |
General discussion |
||
6 | 14:40-15:00 |
Committee Board Reform |
Chu Hui Zeng | Zhongda Hospital Southeast University, China |
7 | 15:00-15:25 |
General discussion |
||
8 | 15:25-15:45 |
Non-invasive Assessment of Portal Hypertension for Evaluating the Prognosis of uHCC: An International Multicenter Cohort Study |
Yu-Qing Wang | Zhongda Hospital, Southeast University, China |
9 | 15:45-16:10 |
General discussion |
||
10 | 16:10-16:30 |
Assessment of liver and spleen stiffness measurement accuracy in predicting the presence of oesophageal varices needing treatment in cirrhotic patients with advanced HCC who undergo systemic therapy |
Xiao-Long Qi | Zhongda Hospital Southeast University, China |
11 | 16:30-16:55 |
General discussion |
||
12 | 16:55-17:15 |
International Society of Multidisciplinary Interventional Oncology (ISMIO) Expert Consensus Statement on Transarterial Chemoembolization Combined with Immunotherapy-Based Systemic Therapy for Hepatocellular Carcinoma |
Bin-Yan Zhong | Zhejiang Cancer Hospital, China |
13 | 17:15-17:40 |
General discussion |
||
14 | 17:40-17:50 |
Close Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:00-14:05 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
2 | 14:05-14:20 |
NEJM and Clinical Research |
Rui-Ping Xiao | Associate Editor, New England Journal of Medicine, China |
3 | 14:20-14:35 |
Why and How to Publish on Med-X Journal? |
Lisa X. Xu | Editors-in-Chief, Med-X, China |
4 | 14:35-14:50 |
Trends and Prospects of Sustainable Growth in STTT |
Qiu Sun | Editor, Signal Transduction and Targeted Therapy, China |
5 | 14:50-15:05 |
The Innovation Journals: Serving Global Reserchers |
Ke Chen | Executive Director, The Innovation, China |
6 | 15:05-15:15 |
Introduction to EngMedicine |
Fu-Gen Wu | Southeast University, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 15:15-15:55 |
Increasing the Proportion of International Submissions |
||
2 | 15:15-15:55 |
Enhancing the Quality of Submissions |
||
3 | 15:15-15:55 |
Improving Citation Rates and Journal Visibility |
||
4 | 15:55-16:00 |
Summary
Xiao-Long Qi
Zhongda Hospital Southeast University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 08:00-08:20 |
Precision Treatment of Triple Negative Breast Cancer |
Zhi-Min Shao | Fudan University Affiliated Cancer Hospital, China |
2 | 08:20-08:40 |
Use of Artificial Intelligence for Imaging and Therapy of HCC |
Julius Chapiro | Yale School of Medicine, USA |
3 | 08:40-09:00 |
Application of Ultra Resolution Microscopy in Tumor Diagnosis and Treatment |
Ping Liang | Chinese PLA General Hospital, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 09:35-09:55 |
Gastroduodenal Stents: Evolution and Future Perspectives |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 10:00-10:20 |
Advancement of Combined Locoregional Therapy with Immunotherapy in HCC |
Gao-Jun Teng | Zhongda Hospital, Southeast University, China |
2 | 10:20-10:40 |
New Horizons of Liver Tumor Treatment |
David C. Madoff | Yale School of Medicine, USA |
3 | 10:40-11:00 |
Multimodal Thermal Therapy for Solid Tumor: A New Interventional Immunomodulatory |
Lisa X. Xu | Shanghai Jiao Tong University, China |
4 | 11:00-11:20 |
Preclinical and Clinical Histotripsy for the Treatment of Liver Cancer |
Maggie (Man) Zhang | University of Michigan, USA |
5 | 11:20-11:40 |
Research on the Mechanisms of Cancer Cachexia and Drug Development |
Rui-Ping Xiao | Peking University, China |
6 | 11:40-12:00 |
Discussion |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 12:30-12:35 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
2 | 12:35-12:40 |
Experts Speech
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China /
Ming Kuang
The First Affiliated Hospital, Sun Yat-Sen University, China /
Hua Xiang
Hunan Cancer Hospital, China /
Guo-Hong Han
Xi'an International Medical Center Hospital, China /
Zhong-Min Wang
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
|
||
3 | 12:40-12:55 |
Structured Research, Limitless Innovation |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
4 | 12:55-13:10 |
laparoscopic liver resection for liver cance |
Lian-Xin Liu | The First Affiliated Hospital of University of Science and Technology of China |
5 | 13:10-13:25 |
Panelists
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Tian-Qiang Song
Tianjin Medical University Cancer Institute & Hospital, China /
Hai-Tao Zhao
Peking Union Medical College Hospital, China /
Hai-Bo Shao
The First Affiliated Hospital of China Meical University, China /
Jia-Ping Li
The First Affiliated Hospital of Sun Yat-sen University, China /
Ming Zhao
Sun Yat-Sen University Cancer Center, China /
Hai-Peng Yu
Tianjin Medical University Cancer Institute & Hospital, China /
Jian Lu
Zhongda Hospital, Southeast University, China /
Bin-Yan Zhong
Zhejiang Cancer Hospital, China /
Wen-Zhe Fan
The First Affiliated Hospital, Sun Yat-Sen University, China
|
||
6 | 13:25-13:30 |
Summary
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
Role of Y90 Radioembolization in Treatment of Large HCCs |
Rickie Lik-Fai Cheng | Princess Margaret Hospital, Hong Kong, China |
2 | 13:42-13:54 |
Combination of TACE with Systemic Therapy for Unresectable HCC |
Zhen-Wei Peng | The First Affiliated Hospital, Sun Yat-Sen University, China |
3 | 13:54-14:06 |
Advanced Forearm Access for Same Day Radiation Segmentectomy |
Uei Pua | Tan Tock Seng Hospital, Singapore |
4 | 14:06-14:18 |
How to Provide More Surgical Opportunities for Patients with HCC Using Minimal Invasive Methods to Increase the Remnant Liver Volume |
Lian-Xin Liu | The First Affiliated Hospital of University of Science and Technology of China |
5 | 14:18-14:30 |
Panelists
Tao Peng
The First Affiliated Hospital of Guangxi Medical University, China /
Ji Hoon Shin
Asan Medical Cente, University of Ulsan College of Medicine, Korea /
Rickie Lik-Fai Cheng
Princess Margaret Hospital, Hong Kong, China /
Zhen-Wei Peng
The First Affiliated Hospital, Sun Yat-Sen University, China /
Uei Pua
Tan Tock Seng Hospital, Singapore /
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:42 |
Combining TACE with Checkpoint Inhibitors for Intermediate-stage HCC |
David C. Madoff | Yale School of Medicine, USA |
2 | 14:42-14:54 |
How to Select 2nd-line Systemic Therapy in Advanced-stage HCC? |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
3 | 14:54-15:06 |
First-line TACE with ICIs and VEGF or TKIs for Intermediate-stage HCC: A Target Trial Emulation Study |
Hai-Dong Zhu | Zhongda Hospital, Southeast University, China |
4 | 15:06-15:18 |
Is Systemic Therapy Alone Sufficient as Standard Treatment for Advanced Stage HCC? |
Xiao-Dong Wang | Beijing Cancer Hospital, China |
5 | 15:18-15:30 |
Panelists
Wan-Guang Zhang
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China /
David C. Madoff
Yale School of Medicine, USA /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Hai-Dong Zhu
Zhongda Hospital, Southeast University, China /
Xiao-Dong Wang
Beijing Cancer Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:12 |
Hepatopancreatoduodenectomy for Widespread Hilar Cholangiocarcinoma |
Kiyoshi Hasegawa | Graduate School of Medicine, The University of Tokyo Hospital, Japan |
2 | 16:12-16:24 |
Surgical and Multidisciplinary Treatment of Intrahepatic Cholangiocarcinoma |
Feng Shen | Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China |
3 | 16:24-16:36 |
Intervention for Biliary Malignancy |
Seung Boo Yang | Nowon Eulji University Hospital, Korea |
4 | 16:36-16:48 |
Neoadjuvant Therapy for BTC — A Medical Oncologist's Perspective |
Yuan Cheng | Jinling Hospital, Nanjing University, China |
5 | 16:48-17:00 |
Panelists
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China /
Hai-Tao Zhao
Peking Union Medical College Hospital, China /
Kiyoshi Hasegawa
Graduate School of Medicine, The University of Tokyo Hospital, Japan /
Feng Shen
Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China /
Seung Boo Yang
Nowon Eulji University Hospital, Korea /
Yuan Cheng
Jinling Hospital, Nanjing University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 17:00-17:12 |
Percutaneous Biliary Metallic Stent Insertion in Patients with Malignant Duodenobiliary Obstruction: Outcomes and Factors Influencing Biliary Stent Patency |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
2 | 17:12-17:24 |
Research Progress and Challenges in Mucosal Melanoma of the Head and Neck |
Wei Guo | Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China |
3 | 17:24-17:36 |
The Value of Integrated Angiography and CT Scan System for Oncologic Interventions |
Kiang Hiong Tay | Singapore General Hospital, Singapore |
4 | 17:36-17:48 |
Same Day Percutaneous Renal Cryoablation : A New Paradigm to Enhancing Patient Care? |
Jun-Jian Huang | Emory University school of medicine, USA |
5 | 17:48-18:00 |
Cool Approach, Clear Result: Lung Cryoablation in Clinical Practice |
Somrach Thamtorawat | Faculty of Medicine Siriraj Hospital, Thailand |
6 | 18:00-18:15 |
Panelists
Alex Tang
Subang Jaya Medical Centre,Malaysia /
Wei-Qian Chen
Zhejiang Lishui Central Hospital, China /
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Wei Guo
Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China /
Kiang Hiong Tay
Singapore General Hospital, Singapore /
Jun-Jian Huang
Emory University school of medicine, USA /
Somrach Thamtorawat
Faculty of Medicine Siriraj Hospital, Thailand
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
Trans-arterial Approach for Treatment of Primary Lung Cancer |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
2 | 13:42-13:54 |
Bronchial Artery Embolization in Hemoptysis: Is Glue Better than PVA? |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
3 | 13:54-14:06 |
Lung Neoplasms—the Role of TACP, TPCE Combined with Thermoablation: Long-term Evaluation |
Thomas J. Vogl | University Hospital Frankfurt, Johann Wolfgang Goethe University, Germany |
4 | 14:06-14:18 |
Current Status of Clinical Application of SBRT in Lung Tumors |
Ya-Ping Xu | Shanghai Pulmonary Hospital, China |
5 | 14:18-14:30 |
Panelists
Xiao-Li Zhu
The First Affiliated Hospital of Soochow University, China /
Shinichi Hori
Institute for Image Guided Therapy, Japan /
Ajit K. Yadav
Sir Ganga Ram Hospital, Delhi, India /
Thomas J. Vogl
University Hospital Frankfurt, Johann Wolfgang Goethe University, Germany /
Ya-Ping Xu
Shanghai Pulmonary Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:42 |
A New Field of Interventional Radiology: Breast Cancer Treatment |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
2 | 14:42-14:54 |
Translational Research in Breast Cancers Metabolism |
Hai Hu | Zhejiang Cancer Hospital, China |
3 | 14:54-15:06 |
Evolution of Antibody-drug-conjugate Therapy for Breast Cancer |
Masakazu Toi | Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan |
4 | 15:06-15:18 |
TBD |
Yong-Mei Yin | Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China |
5 | 15:18-15:30 |
Advances in Breast Cancer Ablation |
Jie Yu | Chinese PLA General Hospital, China |
6 | 15:30-15:45 |
Panelists
Yong-Mei Yin
Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China /
Hai-Peng Yu
Tianjin Medical University Cancer Institute & Hospital, China /
Hai Hu
Zhejiang Cancer Hospital, China /
Masakazu Toi
Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan /
Jie Yu
Chinese PLA General Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:12 |
Contemporary Management of Locally Advanced Pancreas Cancer |
Flavio G. Rocha | Oregon Health and Science University, USA |
2 | 16:12-16:24 |
Precision Management of Pancreatic Cancer in the Era of Multimodal Analysis |
Bai-Yong Shen | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
3 | 16:24-16:36 |
High-voltage Pulse Technology: From Fundamental Principles to Comprehensive Applications in Multiple Fields |
Zhong-Min Wang | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
4 | 16:36-16:48 |
A Personalised Approach in the Treatment of Pancreatic Cancer |
Alexey Zhao | P. A. Herzen Institute of Oncology, Russia |
5 | 16:48-17:00 |
Panelists
Govindarajan Narayanan
Miami Cancer Institute Baptist Health South Florida, USA /
Flavio G. Rocha
Oregon Health and Science University, USA /
Bai-Yong Shen
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China /
Alexey Zhao
P. A. Herzen Institute of Oncology, Russia /
Zhong-Min Wang
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 17:00-17:12 |
Clinical Outcomes of Ablation-osteoplasty-reinforcement-internal Fixation (AORIF) of the Peri-acetabular Metastases from Breast, Lung, Prostate, and Kidney |
Francis Lee | Yale School of Medicine, USA |
2 | 17:12-17:24 |
AI-integrated PTA Treatment |
Aichi Chien | David Geffen School of Medicine at UCLA, USA |
3 | 17:24-17:36 |
Tips and Tricks for Manipulation of Microcatheter |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
4 | 17:36-17:48 |
Transarterial Chemoembolization in the Management of Hepatocellular Carcinoma: An Overview of Global Practices and Emerging Trends |
Tamana Marvin | Philippine Heart Center, Philippines |
5 | 17:48-18:00 |
Technology-enhanced Precision in MIS HPB Surgery |
Alfred Kow Wei Chieh | National University Hospital, Singapore |
6 | 18:00-18:15 |
Panelists
Song Wang
The Affiliated Hospital of Qingdao University, China /
Francis Lee
Yale School of Medicine, USA /
Gao-Feng Shu
Zhejiang Lishui Central Hospital, China /
Aichi Chien
David Geffen School of Medicine at UCLA, USA /
Shinichi Hori
Institute for Image Guided Therapy, Japan /
Tamana Marvin
Philippine Heart Center, Philippines /
Alfred Kow Wei Chieh
National University Hospital, Singapore
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
2 | 13:42-13:54 |
Value Based Care in IR Treatments of Hepatocellular Carcinoma |
Kiang Hiong Tay | Singapore General Hospital, Singapore |
3 | 13:54-14:06 |
MRI-guided Clinically Bacteriplytic Transarterial Embolization for Liver Tumor Therapy |
Zhuo-Li Zhang | University of California, USA |
4 | 14:06-14:18 |
Biomaterials to Assist Interventional Cancer Therapies |
Zhuang Liu | Soochow University, China |
5 | 14:18-14:30 |
Panelists
Lei Zhang
Sun Yat-sen Memorial Hospital, China /
Hong-Shan Zhong
China Medical University, China /
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Kiang Hiong Tay
Singapore General Hospital, Singapore /
Zhuo-Li Zhang
University of California, USA /
Zhuang Liu
Soochow University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:42 |
Development and Application of Early Screening and Diagnosis Technology for Gastric Cancer |
Xiang-Dong Cheng | Zhejiang Cancer Hospital, China |
2 | 14:42-14:54 |
Advancing Y-90 Dosimetry: Personalized Approaches for Hepatocellular Carcinoma |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
3 | 14:54-15:06 |
Surgical Resection with Major Hepatic Vein Reconstruction for Colorectal Liver Metastasis |
Kiyoshi Hasegawa | Graduate School of Medicine, The University of Tokyo Hospital, Japan |
4 | 15:06-15:18 |
Ablation of Liver Cancer: Challenges and Developments |
Ming Kuang | The First Affiliated Hospital, Sun Yat-Sen University, China |
5 | 15:18-15:30 |
Panelists
Fei Gao
Sun Yat-Sen University Cancer Center, China /
Prijo Sidipratomo
Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia /
Xiang-Dong Cheng
Zhejiang Cancer Hospital, China /
Jon C. Davidson
University Hospitals Cleveland Medical Center, USA /
Wei-Ling He
Xiamen University Affiliated Xiang'an Hospital, China /
Kiyoshi Hasegawa
Graduate School of Medicine, The University of Tokyo Hospital, Japan
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:12 |
Different Response Pattern between IO plus Anti-VEGF and IO plus IO Regimens |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
2 | 16:12-16:24 |
Mechanistic Research and Emerging Therapeutic Approaches for Hepatocellular Carcinoma with Pulmonary Metastasis |
Hong Wu | West China Hospital of Sichuan University, China |
3 | 16:24-16:36 |
Combining TACE with Checkpoint Inhibitors for Intermediate-Stage HCC |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
4 | 16:36-16:48 |
Chinese Experience of Perioperative Management for Liver Cancer |
Hong Zhao | Cancer Institute and Hospital, China |
5 | 16:48-17:00 |
Panelists
Hong Wu
West China Hospital of Sichuan University, China /
Le-Du Zhou
Xiangya Hospital of Central South University, China /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Jon C. Davidson
University Hospitals Cleveland Medical Center, USA /
Hong Zhao
Cancer Institute and Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 17:00-17:12 |
Multimodal Therapies and Emerging Insights in Colorectal Cancer Liver Metastases |
Wei-Ling He | Xiamen University Affiliated Xiang'an Hospital, China |
2 | 17:12-17:24 |
Advancements in Irreversible Electroporation Techniques for Kidney Tumors |
Tze Min Wah | St. James's University Hospital, UK |
3 | 17:24-17:36 |
The Evolution of Irreversible Electroporation: Insights from a Decade of Practice |
Govindarajan Narayanan | Miami Cancer Institute Baptist Health South Florida, USA |
4 | 17:36-17:48 |
Microwave Ablation for Large Tumors: Techniques to Minimize Recurrence |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
5 | 17:48-18:00 |
Panelists
Masakazu Toi
Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Japan /
Yong-Yi Zeng
The First Affiliated Hospital of Fujian Medical University, China /
Ming Kuang
The First Affiliated Hospital, Sun Yat-Sen University, China /
Tze Min Wah
St. James's University Hospital, UK /
Govindarajan Narayanan
Miami Cancer Institute Baptist Health South Florida, USA /
Jon C. Davidson
University Hospitals Cleveland Medical Center, USA
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
The Application of AI in HPB Surgery and Oncology |
Alfred Kow Wei Chieh | National University Hospital, Singapore |
2 | 13:42-13:54 |
A Duo-targeting Pan-anticancer Strategy with Potential Interventional Applications |
Yi-Cheng Ni | Southeast University, China |
3 | 13:54-14:06 |
New Data Showing Vascular Changes in Patients with Diabetes: How to Modify Treatment Strategies |
Aichi Chien | David Geffen School of Medicine at UCLA, USA |
4 | 14:06-14:18 |
ALPPS--New Surgical Paradigm to Treat Traditionally-Unresectable Liver Cancer |
Jian Zhou | Zhongshan Hospital, Fudan University, China |
5 | 14:18-14:30 |
Panelists
Guang-Hui Luo
Kiang Wu Hospital, Macau, China /
Han Wang
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China /
Alfred Kow Wei Chieh
National University Hospital, Singapore /
Yi-Cheng Ni
Southeast University, China /
Aichi Chien
David Geffen School of Medicine at UCLA, USA /
Jian Zhou
Zhongshan Hospital, Fudan University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:42 |
Lymphangiography and TD Embolization in Latrogenic Chylous Leaks |
Ajit K. Yadav | Sir Ganga Ram Hospital, Delhi, India |
2 | 14:42-14:54 |
MRI-guided IRE Combined with DC Vaccination for PDAC Treatment |
Zhuo-Li Zhang | University of California, USA |
3 | 14:54-15:06 |
Molecular Imaging Biomarker Development for Combined Immunotherapy and Locoregional Therapy of HCC: From Bench to Bedside |
Julius Chapiro | Yale School of Medicine, USA |
4 | 15:06-15:18 |
Comprehensive TAE Strategy for HCC Based on Thermo-Sensitive Nanogels |
Xiang-Liang Yang | Huazhong University of Science and Technology, China |
5 | 15:18-15:30 |
Towards Precision Medicine: Multi-modal Image Analysis Driven by Artificial Intelligence |
Yang Wang | Zhejiang Cancer Hospital, China |
6 | 15:30-15:45 |
Panelists
Francis Lee
Yale School of Medicine, USA /
Rui-Fang Ni
The First Affiliated Hospital of Soochow University, China /
Ajit K. Yadav
Sir Ganga Ram Hospital, Delhi, India /
Zhuo-Li Zhang
University of California, USA /
Xiang-Liang Yang
Huazhong University of Science and Technology, China /
Julius Chapiro
Yale School of Medicine, USA /
Yang Wang
Zhejiang Cancer Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:10 |
Opening Remarks
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
2 | 16:10-16:25 |
Cryoablation for Locally Advanced Pancreatic Cancer and Pancreatic Metastasis |
Alexey Zhao | P. A. Herzen Institute of Oncology, Russia |
3 | 16:25-16:40 |
Interventional Treatments for Benign and Malignant Breast Masses |
Mehmet Mahir Atasoy | Maltepe University School of Medicine, Turkey |
4 | 16:40-16:55 |
Cryoablation in the Prostate |
Saim Yilmaz | Varisson Radiology Center, Turkey |
5 | 16:55-17:10 |
The role of Thermal Ablation Methods in the Treatment of HCC in the Republic of Kazakhstan |
Niyaz Malayev | National Scientific Medical Center, Kazakhstan |
6 | 17:10-17:25 |
Role of Interventional Radiology in Pain Management of Abdominal Cancer |
Shahzad Bhatti | Mayo Hospital/King Edward Medical University, Pakistan |
7 | 17:25-17:40 |
Co-ablation System in Tumor Therapy: Advancements in Composite Cryo-thermal Ablation for Cancer Treatment |
Li-Zhi Niu | Guangzhou Fuda Cancer Hospital, China |
8 | 17:40-17:55 |
Discussion
Wei-Jun Fan
Sun Yat-sen University Cancer Center, China /
Zhong-Min Wang
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
|
||
9 | 17:55-18:00 |
Conference Summary
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:42 |
New Ice Age of Musculoskeletal Intervention: Role of Percutaneous Cryoablation in Bone and Soft Tissue Tumors |
Jun-Jian Huang | Emory University school of medicine, USA |
2 | 13:42-13:54 |
Super-selective TACE |
Seung Boo Yang | Nowon Eulji University Hospital, Korea |
3 | 13:54-14:06 |
Optimizing Outcomes in Centrally Located HCC: The Evolving Role of Precision Radiotherapy |
Wei-Hu Wang | Beijing Cancer Hospital, China |
4 | 14:06-14:18 |
From Vision to Precision: Image-guided Solutions for Interventional Oncology |
Yu Deuerling Zheng | Siemens Healthineers, Germany |
5 | 14:18-14:30 |
Panelists
Hai-Bin Shi
Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China /
Jun-Jian Huang
Emory University school of medicine, USA /
Seung Boo Yang
Nowon Eulji University Hospital, Korea /
Wei-Hu Wang
Beijing Cancer Hospital, China /
Yu Deuerling Zheng
Siemens Healthineers, Germany
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:30-14:45 |
Transradial HepaSphere Treatment for HCC in AMC |
Ji Hoon Shin | Asan Medical Cente, University of Ulsan College of Medicine, Korea |
2 | 14:45-15:00 |
Combined Immuno-DTACE for Difficult-to-treat Liver Cancer Patients |
Alex Tang | Subang Jaya Medical Centre,Malaysia |
3 | 15:00-15:15 |
Advancing Your Practice in Refractory Liver Cancers Management |
Shinichi Hori | Institute for Image Guided Therapy, Japan |
4 | 15:15-15:30 |
Discussion
Jia-Ping Li
The First Affiliated Hospital of Sun Yat-sen University, China /
Zi-Shu Zhang
Xiangya Hospital Central South University, China /
Hai-Bo Shao
The First Affiliated Hospital of China Meical University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:06 |
Does Needle Biopsy Immediately after Percutaneous Microwave and Cryoablation of Lung Neoplasm Affect Pathological Results? A Clinical and Animal Study |
Jun-Ting Ma | First Hospital of China Medical University, China |
2 | 16:06-16:12 |
Outcomes of First-line Microwave Ablation of Treatment-naive Epidermal Growth Factor Receptor–mutated Advanced Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors |
Sheng Xu | Beijing Hospital, National Center of Gerontology, China |
3 | 16:12-16:18 |
Microwave Ablation versus Lobectomy for Ground-glass Opacity Nodules in the Hilar Region: A Multicenter Prospective Real-world Study on Efficacy and Safety |
Jia-Chang Chi | renji hospital, China |
4 | 16:18-16:24 |
Cryoablation Enhanced Anti-tumor Immunity and Survival for Patients with Liver Metastatic Melanoma Receiving PD-1 Blockade Therapy: Insights from Longitudinal RNA-seq Data |
Chen Li | Sun Yat-sen University Cancer Center, China |
5 | 16:24-16:30 |
Response Evaluation of Liver Directed Therapies for Liver Metastasis in NET |
VARSHA KEDAR | TATA MEMORIAL HOSPITAL, MUMBAI , INDIA |
6 | 16:30-16:36 |
Hepatic Arterial Infusion Chemotherapy with or without Hepatic Artery Chemoembolization for Esophageal Carcinoma Patients with Liver Metastasis: A Clinical Retrospective Study |
Mingrui Yan | Peking University Shougang Hospital,Beijing, China |
7 | 16:36-16:42 |
Drug Eluting Bead Transarterial Chemoembolization (DTACE) Combined with Hepatic Arterial Infusion Chemotherapy versus DTACE Alone for Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer stage C: A Prospective, Multicenter Analysis |
Daqian Han | The First Affiliated Hospital of Zhengzhou University |
8 | 16:42-16:48 |
Comparing Percutaneous and Endoscopic Biliary Drainage in Inoperable Bismuth III/IV Malignant Hilar Biliary Obstruction: Clinical Outcomes and Prognostic Factors |
XIAO-BO FU | Sun Yat-sen University Cancer Center, China |
9 | 16:48-16:54 |
Metformin Suppress Liver Cancer Metastasis by Inhibiting Microwave Ablation Therapy Induced EMT through Modulation of the TGF-β-Smad2/3 Signaling Pathway |
Xian-Mei Liu | Affiliated Hospital of Guizhou Medical University, China |
10 | 16:54-17:00 |
Health Economics Analysis of Three Treatment Methods for Uterine Fibroids |
Yong Jin | The Second Affiliated Hospital of Soochow University, China |
11 | 17:00-17:06 |
Percutaneous Transhepatic Cholangiography in Biliary Obstruction: A Retrospective Audit of Outcomes and Complications |
Sana Sheykhzadeh | Norfolk and Norwich University Hospital |
12 | 17:06-17:12 |
Retrospective Analysis of Diagnostic Accuracy of Image-guided Needle Biopsy of Pancreatic Lesions |
Antariksh Vijan | Tata Memorial Hospital, Mumbai, India |
13 | 17:12-17:18 |
CCL2⁺ Inflammatory Cancer-associated Fibroblasts Promote Chemoresistance and Tumor Progression in Microsatellite Stable Colorectal Cancer via the CCL2-P4HB-NOTCH-STAT3 Axis |
Si-Yuan Weng | National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China |
14 | 17:18-17:24 |
3D-printed Versatile Biodegradable Biliary Stent with Zinc/Sirolimus for Anti-bacterial and Anti-hyperplasia in a Rabbit Bile Duct |
Jung-Hoon Park | Asan Medical Center, Korea |
15 | 17:24-17:30 |
Neoadjuvant Arterial Infusion Chemotherapy versus Intravenous Chemotherapy for Locally Advanced Gastric Cancer: A Long-term Follow-up |
Jun Chen | Zhejiang Provincial People's Hospital, Hangzhou Medical College, China |
16 | 17:30-17:36 |
Whether the Choice of Location for Re-implantation Chest Port Affects the Incidence of Complications in Adult Tumor Patients Undergoing Right Chest Port Removal |
Cao-Ye Wang | Changzhou First People Hospital, China |
17 | 17:36-17:42 |
Direct Percutaneous Embolization of Hypervascular Renal Cell Cancer Metastasis to the Spine |
Calvin Cheong | National University Hospital, Singapore |
18 | 17:42-17:48 |
Long-term Outcomes of Image-guided Ablation and Laparoscopic Partial Nephrectomy for T1 Renal Cell Carcinoma |
Vinson Chan | University of Leeds, United Kingdom |
19 | 17:48-17:54 |
The Status of Cytotoxic Lymphocytes Indicate Therapeutic Efficacy and Prognosis in Patients with Advanced Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Systemic Therapies |
Hai-Feng Zhou | The First Affiliated Hospital of Nanjing Medical University, China |
20 | 17:54-18:00 |
Transjugular Intrahepatic Portosystemic Shunt Plus Transarterial Chemoembolization of Hepatocellular Carcinoma Patients with Portal Vein Tumour Thrombus-related Variceal Bleeding |
Wei-Zhong Zhou | The first affiliated hospital of Nanjing medical university, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:35 |
Welcome Address
Sheng-Hong Ju
Zhongda Hospital, Southeast University, China
|
||
2 | 13:35-13:40 |
ROADS Launch Ceremony |
||
3 | 13:40-14:05 |
How to Evaluate Treatment Response of HCC after Radiation Based Locoregional Treatment: LR-TRA v2024 |
Jeong Min Lee | Seoul National University Hospital, Korea |
4 | 14:05-14:30 |
Recent Advances in Image-Guided Locoregional Therapies for HCC (New Navigation Tools, New Devices, New Techniques) |
Roberto Iezzi | Università Cattolica del Sacro Cuore, Italy |
5 | 14:30-14:55 |
MRI at 0.05 Tesla: A Computing-powered Point-of-care Imaging Device? |
Ed X. Wu | The University of Hong Kong, China |
6 | 14:55-15:20 |
Use of EOB MRI for Imaging of Hepatic Malignancies |
Cher Heng Tan | Tan Tock Seng Hospital, Singapore |
7 | 15:20-15:35 |
Coffee Break |
||
8 | 15:35-16:00 |
Infiltrative HCC: What Every Radiologist Needs to Recognize and Report |
Sahat Matondang | Cipto Mangunkusumo National General Hospita, Indonesia |
9 | 16:00-16:25 |
Hepatocellular Carcinoma beyond Diagnosis: Role of Imaging in Prognostication, Pathology and Genetic Correlation |
Xiao-Yang Liu | The University of Toronto, Canada |
10 | 16:25-16:50 |
Imaging Evalution of the Treatment Response after Locoregional Therapy for HCC |
Yuan-Cheng Wang | Zhongda Hospital, Southeast University, China |
11 | 16:50-17:30 |
ROADS Abdominal Imaging Case Review Webinar |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 13:30-13:35 |
Opening Speakers
Gao-Jun Teng
Zhongda Hospital, Southeast University, China /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Jian Zhou
Zhongshan Hospital, Fudan University, China
|
||
2 | 13:35-13:40 |
ISMIO Meets APPLE: International Consensus Project on TACE Combined with Targeted Therapy and Immunotherapy for HCC
Gao-Jun Teng
Zhongda Hospital, Southeast University, China /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Jian Zhou
Zhongshan Hospital, Fudan University, China /
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China /
Feng Shen
Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China /
Ming Kuang
The First Affiliated Hospital, Sun Yat-Sen University, China /
Hong Wu
West China Hospital of Sichuan University, China
|
||
3 | 13:40-14:00 |
Panel Discussion: CNLC Meets BCLC: Impact of TACE-Targeted-Immunotherapy Advances on International Guideline Updates: Evidence from Global Trials and Clinical Practice
Gao-Jun Teng
Zhongda Hospital, Southeast University, China /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Jian Zhou
Zhongshan Hospital, Fudan University, China /
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China /
Feng Shen
Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China /
Ming Kuang
The First Affiliated Hospital, Sun Yat-Sen University, China /
Hong Wu
West China Hospital of Sichuan University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 08:00-08:12 |
A pilot study for PTMC thermal ablation |
Dong Xu | Zhejiang Cancer Hospital, China |
2 | 08:12-08:24 |
Ultrasound-based management of thyroid nodules: state-of-art and perspective |
Hui-Xiong Xu | Zhongshan Hospital, Fudan University, Shanghai, China |
3 | 08:24-08:36 |
Ablation of Papillary Microcacinoma |
Mehmet Korkmaz | Evliya Çelebi Training & Research Hospital, Turkey |
4 | 08:36-08:48 |
Ablation of Parathyroid Adenomas |
Furkan Erturk Urfali | Bursa City Hospital, Turkey |
5 | 08:48-09:00 |
Surgical Perspectives on Thyroid Anatomy and Strategies for Ablative Treatment of Benign and Malignant Tumors |
Ying Zhou | The First Affiliated Hospital of Hebei University of Chinese Medicine, China |
6 | 09:00-09:12 |
The Role of URM in the Differential Diagnosis of Benign and Malignant Cervical Lymph Nodes: A Preliminary Study |
Ji-Ye Chen | Zhejiang Cancer Hospital, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 09:30-09:36 |
Preparation of a Composite Nanozyme and Its Sonodynamic Therapy in Bladder Cancer |
Jia-Jia Zheng | Zhejiang Provincial People‘s Hospital, China |
2 | 09:36-09:42 |
Trans-arterial Embolisation Prior to Image-guided Ablation for T1b/T2a Renal Masses – A Systematic Review and Meta-analysis |
Aisha Ahmed | University of Leeds |
3 | 09:42-09:48 |
Results of Ultrasound Guided Vacuum Assisted Breast Biopsy Treatment for Benign Breast Tumor |
Batmunkh Erdenebulgan | Second state central hospital, Mongolia |
4 | 09:48-09:54 |
A Nomogram Predicting Venous Thromboembolism Risk in Primary Liver Cancer Patients |
Jing Xiao | Chongqing University Cancer Hospital, China |
5 | 09:54-10:00 |
Breat Thermogram Database Generation to Use AI for Early Breast Cancer Detection |
Bilal Majeed | University of Limerick |
6 | 10:00-10:06 |
Irradiation Modulates sEVs-PD-L1 Transport in TNBC's Tumor Immune Microenvironment |
Yuqin Wei | Wuming Hospital of Guangxi Medical University, China |
7 | 10:06-10:12 |
A Real-world Survey of 1830 Surviving Patients with Adamantinomatous Craniopharyngioma in China |
Zhi-Xiong Lin | Sanbo Brain Hospital, Capital Medical University, China |
8 | 10:12-10:18 |
The Diversity of Arterial Approaches in Delivering Intra-arterial Chemotherapy for Retinoblastoma: Experiences from Indonesia |
Jason Jason | Department of Radiology, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
9 | 10:18-10:24 |
Comparative Effectiveness of Liquid versus Solid Embolic Agents in Pre-surgical Embolization for Intracranial Tumors: A Systematic Review and Meta-analysis |
Yuhang Zhao | Zhongda Hospital, Medical School, Southeast University, China |
10 | 10:24-10:30 |
Percutaneous Catheter Drainage (PCD) as Primary Treatment for Necrotizing Pancreatitis: Clinical Outcomes and Comparative Effectiveness |
Gantulga Vanchinsuren | Second State Center Hospital |
11 | 10:30-10:36 |
Analysis of Short and Medium Term Clinical Effect of Prostatic Artery Embolization on Symptomatic Prostatic Hyperplasia |
Shi-Long Han | Tenth People's Hospital of Tongji University, China |
12 | 10:36-10:42 |
Role of Sclerotherapy in Patients with Vascular Malformations - A Retrospective Study |
Anand Agrawal | |
13 | 10:42-10:48 |
Single-cell RNA Sequencing Identifies the Versican-producing Cells in Tumor Microenvironment of Cervical Cancer |
Meng-Fan Zhang | First Affiliated Hospital of Zhengzhou University, China |
14 | 10:48-10:54 |
Multicentre Real World Outcomes of Irreversible Electroporation for Complex Small Kidney Cancers (REWIRED) |
Vinson Chan | University of Leeds, United Kingdom |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 08:00-08:06 |
CT-Guided Microwave Ablation with Vertebral Augmentation for Spinal Metastases with Posterior Wall Defects |
Kai-Xian Zhang | Tengzhou Central People’s Hospital, China |
2 | 08:06-08:12 |
A Novel Silver Nanoparticles-functionalized Stent for the Treatment of Malignant Stricture of Esophagus |
Yan Fu | National cancer hospital, Beijing, China |
3 | 08:12-08:18 |
Mitochondrial-Cytosolic Cascade Metabolic Regulation System: A Robust Strategy to Disrupt Multipath Energy Replenishment in Cancer Therapy |
Tian-Ming Wang | Xiangya Hospital, Central South University, China |
4 | 08:18-08:24 |
Prevention of Acute Thrombosis with Vascular Endothelium Antioxidative Nanoscavenger |
Yi-Xin Zhong | Southeast University Affiliated Zhongda Hospital, China |
5 | 08:24-08:30 |
Idarubicin-loaded Degradable Hydrogel for TACE Therapy Enhances Anti-tumor Immunity in Hepatocellular Carcinoma |
Xiao-Kai Zhang | Henan Cancer Hospital/ Affiliated Cancer Hospital of Zhengzhou University, China |
6 | 08:30-08:36 |
The Eight Mitochondrial Metabolism-related Genes as Diagnostic Markers for Abdominal Aortic Aneurysm by Integrating Machine Learning Approach |
Yang Zheng | Chongqing University Cancer Hospital |
7 | 08:36-08:42 |
Functionalized Calcium Alginate Microspheres for TACE Immunotherapy via Polarizing Macrophages and Releasing Anti-tumor Immune Exosomes |
Xiao-Ju Guo | Lishui Central Hospital, China |
8 | 08:42-08:48 |
Celecoxib and Cisplatin Dual-loaded Microspheres Synergistically Enhance Transarterial Chemoembolization Effect of Hepatocellular Carcinoma |
Xin-Wei Han | The First Affiliated Hospital of Zhengzhou University, China |
9 | 08:48-08:54 |
Synergistic Quad-modal Nanoembolics: pH/NIR-Driven Chemo-photothermal Ablation with Immune Reprogramming for HCC |
Wan-Qing Shen | the first affiliated hospital of sun yat-sen university, China |
10 | 08:54-09:00 |
Restraining Small Extracellular Vesicles: Dawn of A New Era in Nanomedicine |
Ming Yang | Zhongda Hospital, Southeast University, China |
11 | 09:00-09:06 |
Engineered Macrophage Membrane-mimicking Nanodrugs Activate the cGAS/STING Pathway to Reverse the Immune-suppressive Microenvironment Induced by RFA |
Wei-Hua Zhang | Zhongda hospital, Southeast University, China |
12 | 09:06-09:12 |
Development and Functional Research of an Irradiation-cytokine Composite Stent for Modulating Immune Microenvironment Reprogramming |
Juan Qin | Zhongda Hospital, Medical School, Southeast University, China |
13 | 09:12-09:18 |
Tailored Liposomal Nanomedicine Suppresses Incomplete Radiofrequency Ablation-induced Tumor Relapse by Reprogramming Antitumor Immunity |
Duo Wang | zhongda hospital, southeast university, China |
14 | 09:18-09:24 |
Autocatalytic Pyroptosis Agonists Modulate Tumor Metabolism and Enhance TACE Efficacy in HCC Therapy |
Lin-Zhu Zhang | Zhongda Hospiital, Southeast University, China |
15 | 09:24-09:30 |
Injectable Hydroxyapatite Radiopaque Microspheres: The Next-generation Material for Cancer Interventional Embolization? |
Yi-Nan Ding | sciences zhejiang cancer hospital, China |
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 09:30-09:36 |
First-in-Human Study of an Artificial Intelligence Integrated Robot for Image-Guided, Trans-Thoracic Lung Biopsy under Local Anaesthesia |
Nadia Rojas | Singapore General Hospital, Singapore |
2 | 09:36-09:42 |
Cancer-Associated Fibroblasts-Derived SEMA3C Facilitates Colorectal Cancer Liver Metastasis via NRP2-Mediated MAPK Activation. |
Yuyuan Zhang | The First Affiliated Hospital of Zhengzhou University, China |
3 | 09:42-09:48 |
Global Interest of Interventional Radiology and Interventional Oncology: A Review of a Decade Using The Google Trends Platform |
Vinson Chan | University of Leeds, United Kingdom |
4 | 09:48-09:54 |
Quantification of Habitat Imaging Combined with Peritumoral Microenvironment Evolution for Predicting Extracapsular Extension in Prostatic Cancer |
Ye Xiang | Leshan Hospital,Chengdu University of TCM, China |
5 | 09:54-10:00 |
Harmonizing Ancient Wisdom and Modern Technology: Exploring Retrieval-Augmented Generation (RAG) with Large Language Models to Transform Education in Interventional Oncology |
Hassan Magdy | Gastrointestinal Surgery Center, Mansoura University, Egypt |
6 | 10:00-10:06 |
Conventional Oral Morphine vs. IV Patient-Controlled Analgesia (IPCA) with Hydromorphone (HM) Continuous Infusion plus Rescue Dose (CIRD) or Bolus-Only (BO) for Severe Cancer Pain: A Randomized Phase III study |
Liyu Su | Fujian Cancer Hospital, China |
7 | 10:06-10:12 |
Efficacy Comparison of Liver Venous Deprivation and TACE Combined with Targeted and Immunotherapies in Unresectable Hepatocellular Carcinoma with Insufficient FLR Volume |
Ying Yang | West China Hospital, Sichuan University, China |
8 | 10:12-10:18 |
Spatial Transcriptomics Reveals Tryptophan Metabolism Restricting Maturation of Intratumoral Tertiary Lymphoid Structures |
Shuling Chen | The First Affiliated Hospital of Sun Yat-sen University, China |